The mechanism of long-term low-dose asymmetric dimethylarginine inducing transforming growth factor-β expression in endothelial cells

Author：          

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.31, Iss.1, 2013-01, pp. : 67-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy

By        

International Journal of Molecular Medicine, Vol. 30, Iss. 6, 2012-01 ,pp. : 1275-1280

Spandidos Publications

Access to resources Recommend Favorite

Transforming growth factor‐β and psoriasis: a new link

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1480-1481

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of transforming growth factor‐β after different non‐invasive facial rejuvenation modalities

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 4, 2015-04 ,pp. : 396-404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Eosinophils Have an Intact Smad Signaling Pathway Leading to a Major Transforming Growth Factor-β Target Gene Expression

By  

International Archives of Allergy and Immunology, Vol. 142, Iss. 4, 2006-11 ,pp. : 309-317

Karger

Access to resources Recommend Favorite

The Pathophysiology of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β in Normal and Malignant Mammary Epithelial Cells

By Taylor Molly   Parvani Jenny   Schiemann William  

Journal of Mammary Gland Biology and Neoplasia, Vol. 15, Iss. 2, 2010-06 ,pp. : 169-190

Springer Publishing Company

Access to resources Recommend Favorite